Cargando…

A risk assessment study of SARS-CoV-2 propagation in the manufacturing of cellular products

The potential infection of cellular therapies by SARS-CoV-2 present high risks, as the target patients for these treatments are often immunocompromised or have chronic diseases associated with a higher risk of serious illness and death by COVID-19. The multicellular tropism of this virus presents ch...

Descripción completa

Detalles Bibliográficos
Autores principales:	Monte, Enric Redondo, O'Neill, David, Abitorabi, Karin M
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Future Medicine Ltd 2022
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9724788/ https://www.ncbi.nlm.nih.gov/pubmed/36453030 http://dx.doi.org/10.2217/rme-2022-0096

Ejemplares similares

Propagation, Inactivation, and Safety Testing of SARS-CoV-2
por: Jureka, Alexander S., et al.
Publicado: (2020)

Adaptive SIR model for propagation of SARS-CoV-2 in Brazil
por: dos Santos, I.F.F., et al.
Publicado: (2021)

Functional landscape of SARS-CoV-2 cellular restriction
por: Martin-Sancho, Laura, et al.
Publicado: (2021)

A SARS-CoV-2 outbreak in a plastics manufacturing plant
por: Graham, Alice, et al.
Publicado: (2023)

SARS-CoV-2 cellular tropism
por: Cagno, Valeria
Publicado: (2020)

A New Transmission Route for the Propagation of the SARS-CoV-2 Coronavirus
por: Danchin, Antoine, et al.
Publicado: (2020)

SARS-CoV-2 can infect and propagate in human placenta explants
por: Fahmi, Amal, et al.
Publicado: (2021)

Investigation of a SARS-CoV-2 Outbreak at an Automotive Manufacturing Site in England
por: Raja, Amber I., et al.
Publicado: (2022)

Cellular basis for SARS-CoV-2 infection
por: Baumann, Kim
Publicado: (2020)

SARS-CoV-2 isolation and propagation from Turkish COVID-19 patients
por: TAŞTAN, Cihan, et al.
Publicado: (2020)

SARS-CoV-2 promotes RIPK1 activation to facilitate viral propagation
por: Xu, Gang, et al.
Publicado: (2021)

Contamination of SARS-CoV-2 RT-PCR probes at the oligonucleotide manufacturer
por: Wang, Claire Y.T., et al.
Publicado: (2020)

Comparative genomic analysis demonstrates that true reinfection following SARS-CoV-2 infection is possible
por: O Murchu, Eamon, et al.
Publicado: (2021)

Rapid Manufacturing of Highly Cytotoxic Clinical-Grade SARS-CoV-2-specific T Cell Products Covering SARS-CoV-2 and Its Variants for Adoptive T Cell Therapy
por: Bonifacius, Agnes, et al.
Publicado: (2022)

Trigeminal neuropathy presenting secondary to SARS-CoV-2 infection
por: O'Neill, Francis, et al.
Publicado: (2023)

SARS-CoV-2 tropism, entry, replication, and propagation: Considerations for drug discovery and development
por: Murgolo, Nicholas, et al.
Publicado: (2021)

Modeling SARS-CoV-2 propagation using rat coronavirus-associated shedding and transmission
por: Zeiss, Caroline J., et al.
Publicado: (2021)

Persistent Cellular Immunity to SARS-CoV-2 Infection
por: Breton, Gaëlle, et al.
Publicado: (2020)

Persistent cellular immunity to SARS-CoV-2 infection
por: Breton, Gaëlle, et al.
Publicado: (2021)

Contribution of Syndecans to the Cellular Entry of SARS-CoV-2
por: Hudák, Anett, et al.
Publicado: (2021)

Convalescent plasma for SARS-CoV-2 infection: win or learn
por: Contreras-Barbeta, Enric, et al.
Publicado: (2022)

Profile of SARS-CoV-2
por: Heinz, Franz X., et al.
Publicado: (2020)

Assessing wastewater-based epidemiology for the prediction of SARS-CoV-2 incidence in Catalonia
por: Joseph-Duran, Bernat, et al.
Publicado: (2022)

The duration of infectiousness of individuals infected with SARS-CoV-2
por: Walsh, Kieran A., et al.
Publicado: (2020)

A cautionary perspective regarding the isolation and serial propagation of SARS-CoV-2 in Vero cells
por: Funnell, Simon G. P., et al.
Publicado: (2021)

Interpretable network propagation with application to expanding the repertoire of human proteins that interact with SARS-CoV-2
por: Law, Jeffrey N, et al.
Publicado: (2021)

Limited Propagation of SARS-CoV-2 among Children in a Childcare Center, Canada, 2021
por: Li, Toni, et al.
Publicado: (2022)

Financial earthquakes: SARS-CoV-2 news shock propagation in stock and sovereign bond markets
por: Pagnottoni, Paolo, et al.
Publicado: (2021)

575. Local Experience of Breakthrough SARS-CoV-2 Infections After Full Vaccination
por: Khan, Ahmed A, et al.
Publicado: (2021)

Mechanisms of Dysregulated Humoral and Cellular Immunity by SARS-CoV-2
por: Taefehshokr, Nima, et al.
Publicado: (2020)

Identification of Cellular Factors Required for SARS-CoV-2 Replication
por: Synowiec, Aleksandra, et al.
Publicado: (2021)

Rapid SARS-CoV-2 Adaptation to Available Cellular Proteases
por: Chaudhry, M. Zeeshan, et al.
Publicado: (2022)

Cellular therapies for the treatment and prevention of SARS-CoV-2 infection
por: Conway, Susan R., et al.
Publicado: (2022)

Viral and cellular translation during SARS‐CoV‐2 infection
por: Eriani, Gilbert, et al.
Publicado: (2022)

Choosing a cellular model to study SARS-CoV-2
por: Pires De Souza, Gabriel Augusto, et al.
Publicado: (2022)

Cellular immune states in SARS-CoV-2-induced disease
por: Mortezaee, Keywan, et al.
Publicado: (2022)

Umbelliferone and eriodictyol suppress the cellular entry of SARS-CoV-2
por: Cheng, Fang-Ju, et al.
Publicado: (2023)

Palmar rash for the new coronavirus SARS-CoV-2()
por: Novo de Matos, Joao, et al.
Publicado: (2020)

Throughput-scalable manufacturing of SARS-CoV-2 mRNA lipid nanoparticle vaccines
por: Shepherd, Sarah J., et al.
Publicado: (2023)

Anti-SARS-CoV Natural Products With the Potential to Inhibit SARS-CoV-2 (COVID-19)
por: Verma, Surjeet, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_bi1o085e4h63h2ohr8te242cie